p63-positive prostate carcinoma-A very rare presentation

Sanjana B. Lokesha, Beshwanth V. Chowdary, Jyoti R. Kini

Research output: Contribution to journalArticlepeer-review


Prostate cancer being the world's leading cause of cancer and also the second most common cancer in men is posing challenges in its diagnosis. Immunohistochemistry with markers like high molecular weight cytokeratin, p63 aid in the diagnosis. The absence of p63 and high molecular weight cytokeratin and presence of p504s in the biopsies indicate malignant lesions. Yet, there is a loophole to this too. A rare case of p63-positive prostatic adenocarcinoma in an 87-year-old patient, with immunohistochemistry results showing overexpression of p63 in the nuclei of the malignant glands. This tumor shows high molecular weight cytokeratin negativity, and p504s positivity. Prognosis of this variant of the tumor is mostly favorable. Prompt treatment will halt the progression of this tumor and prevent paraplegia. Radical prostatectomy could be avoided by treatment modalities like androgen blockade and brachytherapy, as morbidity is very high with radical prostatectomy surgery.

Original languageEnglish
Pages (from-to)448-451
Number of pages4
JournalIndian journal of pathology & microbiology
Issue number2
Publication statusPublished - 01-04-2022

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Microbiology (medical)


Dive into the research topics of 'p63-positive prostate carcinoma-A very rare presentation'. Together they form a unique fingerprint.

Cite this